TNFAIP8L2: Key Regulator of Inflammation and Cell Signaling (G79626)

Target Name: TNFAIP8L2

NCBI ID: G79626

TNFAIP8L2

TNFAIP8L2: Key Regulator of Inflammation and Cell Signaling

Tumor necrosis factor, alpha-induced protein 8-like protein 2 (TNFAIP8L2) is a protein that is expressed in various tissues throughout the body, including the liver, spleen, lung, and gastrointestinal tract. It is a key regulator of the immune response and has been implicated in a number of diseases, including cancer.

One of the key functions of TNFAIP8L2 is its role in the regulation of inflammation. TNFAIP8L2 has been shown to play a key role in the production of pro-inflammatory cytokines, such as TNF-alpha and IL-12, and has been shown to inhibit the production of anti-inflammatory cytokines, such as IL-10. This contributes to the pro-inflammatory effects of TNFAIP8L2 and the development of inflammatory diseases.

Another function of TNFAIP8L2 is its role in cell signaling. TNFAIP8L2 has been shown to play a key role in the regulation of cell signaling pathways, including the JAK/STAT signaling pathway. This pathway is involved in the regulation of immune responses and has been implicated in the development of a number of diseases, including cancer.

In addition to its role in inflammation and cell signaling, TNFAIP8L2 has also been shown to play a role in the regulation of cellular processes such as cell adhesion and migration. TNFAIP8L2 has been shown to be involved in the regulation of integrins, which are important for cell adhesion and migration. This contributes to the role of TNFAIP8L2 in the development of cancer, as changes in integrin function have been implicated in the development of cancer cells.

TNFAIP8L2 has also been shown to play a role in the regulation of the immune response. TNFAIP8L2 has been shown to play a key role in the regulation of T cell development and function, as well as the regulation of T cell receptor (TCR) function. This contributes to the role of TNFAIP8L2 in the development of autoimmune diseases, as changes in T cell function have been implicated in the development of autoimmune diseases.

Despite the many promising findings for the role of TNFAIP8L2 in disease, more research is needed to fully understand its functions and potential as a drug target or biomarker. Further research is needed to determine the exact mechanisms by which TNFAIP8L2 functions and to explore its potential as a therapeutic agent.

In conclusion, TNFAIP8L2 is a protein that has been shown to play a key role in the regulation of inflammation, cell signaling, and cellular processes, as well as the immune response. Further research is needed to fully understand its functions and potential as a drug target or biomarker.

Protein Name: TNF Alpha Induced Protein 8 Like 2

Functions: Acts as a negative regulator of innate and adaptive immunity by maintaining immune homeostasis. Negative regulator of Toll-like receptor and T-cell receptor function. Prevents hyperresponsiveness of the immune system and maintains immune homeostasis. Inhibits JUN/AP1 and NF-kappa-B activation. Promotes Fas-induced apoptosis (By similarity)

The "TNFAIP8L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TNFAIP8L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets